Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs

Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients

(2020) Rongjuan Chen et al.   ANTIVIRAL RESEARCH

Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice

(2019) Yan Liu et al.   Emerging Microbes & Infections

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

(2019) Eun-Sook Park et al.   JOURNAL OF HEPATOLOGY

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

(2018) Norah A. Terrault et al.   HEPATOLOGY

Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient

(2018) Quan Zhang et al.   VIRUS RESEARCH

Long-Term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection

(2018) Hye Won Lee et al.   Clinical Gastroenterology and Hepatology

Chronic hepatitis B virus infection

(2018) Wai-Kay Seto et al.   LANCET

Management of Antiviral Resistance in Chronic Hepatitis B

(2017) Young-Suk Lim   Gut and Liver

How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?

(2017) Neil Rajoriya et al.   JOURNAL OF HEPATOLOGY

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Hepatitis B virus reverse transcriptase – Target of current antiviral therapy and future drug development

(2015) Daniel N. Clark et al.   ANTIVIRAL RESEARCH

Characterization of novel entecavir resistance mutations

(2015) Sanae Hayashi et al.   JOURNAL OF HEPATOLOGY

Screening and identification of a novel adefovir dipivoxil-resistance-associated mutation rtN236V of HBV from a large cohort of HBV-infected patients

(2014) Yan Liu et al.   ANTIVIRAL THERAPY

The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil

(2014) Y. Liu et al.   JOURNAL OF VIRAL HEPATITIS

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance

(2013) Fabien Zoulim et al.   LIVER INTERNATIONAL

The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation

(2012) Dong Ji et al.   JOURNAL OF CLINICAL VIROLOGY

Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

(2012) Soon Sun Kim et al.   JOURNAL OF MEDICAL VIROLOGY

Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B

(2010) Yan Liu et al.   ANTIVIRAL THERAPY

Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection

(2010) Y. Liu et al.   JOURNAL OF VIRAL HEPATITIS

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

(2009) Ju Hyun Shim et al.   HEPATOLOGY

In Vitro Characterization of Viral Fitness of Therapy-Resistant Hepatitis B Variants

(2008) Stéphanie Villet et al.   GASTROENTEROLOGY